Form D · Biotechnology
Celtaxsys, Inc.
Atlanta, GA · CIK 0001334381
Offering snapshot reported Jun 17, 2015 · SEC filing
- Reported sold
- $21.6M Offering amount: $40M
- Investors reported
- 8 Form D · investor count
- Minimum accepted
- $0 Reported outside-investor minimum
- First sale
- Jun 3, 2015 As reported in this filing
What changed?
Latest filing versus its linked predecessor, where available.
No comparable changes in the displayed metrics.
Filing history
Scroll to see all columns →
| Filed | Filing type | Reported sold | Change vs linked filing | Investors | Source |
|---|---|---|---|---|---|
| Jun 17, 2015 | Initial | $21,628,985 | No comparison | 8 | SEC filing |
| Oct 29, 2010 | Initial | $4,231,386 | No comparison | 6 | SEC filing |
| May 7, 2009 | Initial | $2,040,000 | No comparison | Not reported | SEC filing |
| May 19, 2008 | Paper | Not reported | No comparison | Not reported | SEC filing |
| Jul 25, 2005 | Paper | Not reported | No comparison | Not reported | SEC filing |
Offering details
- Securities
- Equity
- Exemptions
- 06b
- Duration over one year
- No
- Business combination
- No
- Sales commissions
- $1M
- Finders' fees
- $0
- Form D file number
- 021-241945
Sales compensation recipients
Scroll to see all columns →
| Recipient | CRD | Associated broker-dealer |
|---|---|---|
| Livingston Securities, LLC | 147364 | Livingston Securities, LLC · CRD 147364 |
Source: Form D, filed Jun 17, 2015. Minimum accepted may differ from a standard advertised minimum.
Fund connections
No confirmed ADV fund connection is available for this issuer.
People & organizations
Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.
| Name | Reported role |
|---|---|
| Sanjeev Ahuja, M.D. | Executive |
| Gerry Brunk | Director |
| Matthew S. Dontzin | Director |
| Greg Duncan | Director, Executive |
| Maxim Gorbachev | Director |
| Ralph A. Grosswald | Executive |
| Michael Hanley | Director |
| Jan M. Lodal | Director |
| Michael W. Masters | Director |
| H. Daniel Perez, M.D. | Director |
| William P. Reddick | Executive |
| Eric Springman | Executive |
| Nicole Vitullo | Director |
Issuer details
Industry: Biotechnology (See others in industry)
Address:
201 17th Street Suite 530
Atlanta, GA, 30363
Atlanta, GA, 30363